Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture

British Journal of Pharmacology

Volumn 118, Issue 7, 1996, Pages 1597-1604

  De Brum Fernandes, Artur J ^a   Morisset, Sophie ^a   Bkaily, Ghassan ^b   Patry, Caroline ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Arthritis; Cartilage; Chondrocyte; Osteoarthritis; Prostacyclin; Prostaglandin E2; Prostaglandin receptors

Indexed keywords

11 DEOXY 16 PHENOXY 17,18,19,20 TETRANORPROSTAGLANDIN E1; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; BUTAPROST; CALCIUM; CALCIUM CHANNEL; CARBACYCLIN; CYCLIC AMP; FORSKOLIN; INOSITOL TRISPHOSPHATE; INTERLEUKIN 1; METALLOPROTEINASE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PROSTAGLANDIN D2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROTEOGLYCAN; RECEPTOR SUBTYPE; SULPROSTONE; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSINE TRIPHOSPHATE; INOSITOL PHOSPHATE; LIGAND; PROSTAGLANDIN E; PROSTAGLANDIN E RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CARTILAGE CELL; CATTLE; CELL CULTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; ANIMAL; ARTICULAR CARTILAGE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CARTILAGE, ARTICULAR; CATTLE; CELLS, CULTURED; CYCLIC AMP; DINOPROSTONE; GTP-BINDING PROTEINS; INOSINE TRIPHOSPHATE; INOSITOL PHOSPHATES; LIGANDS; PROSTAGLANDINS E, SYNTHETIC; RECEPTORS, PROSTAGLANDIN E; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 0029657965     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15580.x     Document Type: Article

References (51)

1. ADAM, M., BOIE, Y., RUSHMORE, T.H., MULLER, G., BASTIEN, L., MCKEE, K.T., METTERS, K.M. & ABRAMOVITZ, M. (1994). Cloning and expression of three isoforms of the human EP3 prostanoid receptor. FEBS Lett., 338, 170-174.
2. AIKEN, J.W. & SHEBUSKI, R.J. (1980). Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6α-carba-PGI2 (Carbacyclin). Prostaglandins, 19, 629-643.
3. 2. Biochem. Biophys. Res. Commun., 197, 263-270.
4. ATIK, O.S. (1990). Leukotriene B4 and prostaglandin E2-like activity in synovial fluid in osteoarthritis. Prostaglandins Leukotrienes Ess. Fatty Acids, 39, 253-254.
5. BARAGI, V.M., DUDLEY, D.T. & SCHRIER, D.J. (1989). The phosphatidylinositol response of chondrocytes in culture. Agents Actions, 27, 428-430.
6. BASTIEN, L., SAWYER, N., GRYGORCZK, R., METTERS, K.M. & ADAM, M.A. (1994). Cloning, functional expression and characterization of the human prostaglandin E2 receptor EP2 subtype. J. Biol. Chem., 269, 11873-11877.
7. + channels in VSM pathophysiology. In Ionic Channels in Vascular Smooth Muscle, ed. Bkaily, G. pp. 103-113. Georgetown, USA: R.G. Landes Co.
8. BOULAY, G., GALLO-PAYET, N. & GUILLEMETTE, G. (1990). Implication of phospholipase C in the steroidogenic action of angiotensin II. Eur. J. Pharmacol., 189, 267-275.
9. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
10. 3 receptor. J. Biol. Chem., 269, 6163-6169.
11. BREYER, M.D., JACOBSON, H.R., DAVIS, L.S. & BREYER, R.M. (1993). In situ hybridization and localization of mRNA for the rabbit prostaglandin EP3 receptor. Kidney Int., 43, 1372-1378.
12. BURNS, D.L., HEWLETT, E.L., MOSS, J. & VAUGHAN, M. (1983). Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells. J. Biol. Chem., 258, 1435-1438.
13. COLEMAN, R.A., GRIX, S.P., HEAD, S.A., LOUTTIT, J.B., MALLET, A. & SHELDRICK, R.L.G. (1994a). A novel inhibitory receptor in piglet saphenous vein. Prostaglandins, 47, 151-168.
14. COLEMAN, R.A., HUMPHREY, J.M., SHELDRICK, R.L.G. & WHITE, B.P. (1988). Gastric antisecretory prostanoids: actions at different prostanoid receptors. Br. J. Pharmacol., 95, 724P.
15. COLEMAN, R.A., HUMPHREY, P.P.A., KENNEDY, I & LUMLEY, P (1984). Prostanoid receptors - the development of a working classification. Trends Pharmacol. Sci., 5, 303-306.
16. COLEMAN, R.A., KENNEDY, I., HUMPHREY, P.P.A., BUNCE, K. & LUMLEY, P. (1990). Prostanoids and their receptors. In Comprehensive Medicinal Chemistry, ed. Emmett, J.C. p. 643. Oxford: Pergamon Press.
17. 2-sensitive (EP-) receptors. Br. J. Pharmacol., 91, 407P.
18. COLEMAN, R., SMITH, W.L. & NARUMIYA, S (1994b) VIII. International Union of Pharmacology Classification of Prostanoid Receptors: Properties, distribution, and structure of the receptor and their subtypes. Pharmacol. Rev., 46, 205-229.
19. CREESE, B.R. & DENBOROUGH, M. A. (1981). Sources of calcium for contraction of guinea-pig isolated trachea smooth muscle. Clin. Exp. Pharmacol. Physiol., 8, 175-182.
20. DAYER, J.M., ROBINSON, D.R. & KRANE, S.M. (1977). Prostaglandin production by rheumatoid synovial cells. J. Exp. Med., 145, 1399-1404.
21. DE VRIES, G.W., GUARINO, P., MCLAUGHLIN, A., CHEN, J., ANDREWS, S. & WOODWARD, D.F. (1995). An EP receptor with a novel pharmacological profile in the T-cell line Jurkat. Br. J. Pharmacol., 115, 1231-1234.
22. FUNK, C.D., FURCI, L , FITZGERALD, G.A., GRYGORCZYK, R., ROCHETTE, C., BAYNE, M.A., ABRAMOVITZ, M., ADAM, M. & METTERS, K.M. (1993). Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J. Biol. Chem., 268, 26767-26772.
23. GORMAN, R.R., BUNTING, S. & MILLER, O.V. (1977). Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins, 13, 377-388.
24. HONDA, A., SUGIMOTO, Y., NAMBA, T., WATANABE, A., IRIE, A., NEGISHI, M., NARUMIYA, S. & ICHIKAWA, A. (1993). Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J. Biol. Chem., 268, 7759-7762.
25. 3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur. J. Biochcm., 217, 313-318.
26. 2-responsive cell line from bovine embryonic trachea. Br. J. Pharmacol., 99, 13-14.
27. 2 effects on corneal endothelial cyclic adenosine monophosphate synthesis and cell shape are mediated by a receptor of the EP2 subtype. Invest. Opthalmol. Vis. Sci., 32, 360-365.
28. KATADA, T. & UI, M. (1979). Islet-activating protein. Enhanced insulin secretion and cyclic AMP accumulation in pancreatic islets due to activation of native calcium ionophores. J. Biol. Chem., 254, 469-479.
29. KATADA, T. & UI, M. (1981). Islet-activating protein. A modifier of receptor-mediated regulation of rat islet adenylate cyclase. J. Biol. Chem., 256, 8310-8317.
30. KENAKIN, T.P. (1987). Drug antagonism. In Pharmacologic Analysis of Drug-Receptor Interaction. pp. 205-244. New York: Raven Press.
31. KENNEDY, L, COLEMAN, R.A., HUMPHREY, P.P.A., LEVY, G.P. & LUMLEY, P. (1982). Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins, 24, 667-689.
32. KUROSE, H., KATADA, T., HAGA, K., ICHIYAMA, A. & UI, M (1986). Functional interaction of purified muscarinic receptors with purified inhibitory guaninine nucleotide regulatory proteins reconstituted in phospholipid vesicles. J. Biol. Chem., 261, 5423-5428.
33. LAW, S.F., WOULFE, D. & REISINE, T. (1995). Somatostatin receptor activation of cellular effector systems. Cell. Signalling, 7, 1-8.
34. LAWRENCE, R.A., JONES, R.L. & WILSON, N.H. (1992). Characterization of the receptors involved in the direct and indirect actions of prostaglandins E and I in the guinea-pig ileum. Br. J. Pharmacol., 105, 271-278.
35. MALEMUD, C. & SOKOLOFF, L. (1977). The effect of prostaglandins on cultured lapine articular chondrocytes. Prostaglandins, 13, 845-859.
36. NAMBA, T., SUGIMOTO, Y., NEGISHI, M. IRIE, A., USHIKUBI, F., KAKIZUKA, A., ITO, S., ICHIKAWA, A. & NARUMIYA, S. (1993). Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature, 365, 166-170.
37. 3 subtype. Different COOH-terminal domains determine sensitivity to agonist-induced desensitization. J. Biol. Chem., 268, 9517-9521.
38. NISHIGAKI, N., NEGISHI, M., HONDA, A., SUGIMOTO, Y., NAMBA, T., NARUMIYA, S. & ICHIKAWA. A. (1995). Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells as EP4 subtype. FEBS Lett., 364, 339-341.
39. OHIA, S.E. & JUMBLATT, J.E. (1990). Prejunctional inhibitory effects of prostanoids on sympathetic neurotransmission in the rabbit iris-ciliary body. J. Pharmacol. Exp. Ther., 255, 11-16.
40. PELLETIER, J.-P. & MARTEL-PELLETIER, J. (1989). Evidence for the involvement of interleukin 1 in human osteoarthritis cartilage degradation: protective effect of NSAID. J. Rheumatol., 16, 19-27.
41. PELLETIER, J.-P. & MARTEL-PELLETIER, J. (1993). Articular cartilage. In Primer on The Rheumatic Diseases. Tenth edition. ed. Schumacher, H.R., Klippel, J.H. & Koopman, W.J. pp. 8-11. Atlanta: Arthritis Foundation.
42. PERKINS, W.E., BURTON, E.G., TSAI, B.S., COLLINS, P.W., CASLER, J.J., GASIECKI, A.F., BAUER, R.F., JONES, P.H. & GAGINELLA, T.S. (1991). SC-46275: A potent, long-acting gastric antisecretory prostaglandin with low oral bioavialability in the dog. J. Pharmacol. Exp. Ther., 259, 1004-1007.
43. PIERCE, K.L., GIL, D.W., WOODWARD, D.F. & REGAN, J.W. (1995). Cloning of human prostanoid receptors. Trends Pharmacol. Sci., 16, 253-256.
44. PLESS, J., BAUER, W., BRINER, U., DOEPFNER, W., MARBACH, P., MAURER, R., PETCHER, T.J., REUBI, J.-C. & VONDERSCHER, J. (1986). Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin. Scand. J. Gastroenterol., 21, 54-64.
45. REGAN, J.W., BAILEY, T.J., PEPPERL, D.J., PIERCE, K.L., BOGARDUS, A.M., DONELLO, J.E., FAIRBAIRN, C.E., KEDZIE, K.M., WOODWARD, D.F. & GIL, D.W. (1994). Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol., 46, 213-220.
46. SHELDRICK, R.L.G., COLEMAN, R.A. & LUMLEY, P. (1988). Iloprost-A potent EP1 and IP receptor agonist. Br. J. Pharmacol., 94, 334P.
47. 3 receptor. Prostaglandins, 43, 559-566.
48. VIGNON, E., MATHIEU, P., LOUISOT, P., VILAMITJANA, J., HARMAND, M.F. & RICHARD, M. (1989). Phospholipase A2 activity in human osteoarthritic cartilage. J. Rheumatol., 16, 35-38.
49. VIOLLET, C., PREVOST, G., MAUBERT, E., FAIVRE-BAUMAN, A., GARDETTE, R., KORDON, C., LOUDES, C, SLAMA, A. & EPELBAUM, J. (1995). Molecular pharmacology of somatostatin receptors. Fund. Clin. Pharmacol., 9, 107-113.
50. 1 subtype of prostaglandin E receptor. J. Biol. Chem., 268, 20175-10178.
51. WHITTLE, B.J.R., MONCADA, S.. WHITING, F. & VANE. J.R. (1980). Carbacyclin-a potent stable prostacyclin analogue for the inhibition of platelet aggregation. Prostaglandins, 19, 605-627.